BEAT | Ticker Profile - Titan Protect

BEAT

HeartBeam, Inc.

Healthcare · Health Information Services · NCM

$0.84

Data: 2026-05-15

✓ ETHICAL PASS

MOAT

MODERATE

Data Confidence: 57.1%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$55M

Total market value of the company

Trailing P/E

N/A

Forward P/E

-1.86

Based on estimated future earnings — lower means cheaper

Rev Growth

N/A

Year-over-year revenue change

Profit Margin

N/A

How much profit the company keeps from each dollar of revenue

ROE

-495.6%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$5.83

+595% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 3 analysts covering this stock

About HeartBeam, Inc.

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

https://www.heartbeam.com

Country: United States Employees: 16 Industry: Health Information Services

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PASS

Debt must be below 33% of total assets

Cash Ratio

8.3% PASS

Interest-bearing cash below 33% of assets

Receivables

0.0% PASS

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

0.043

Positive but modest risk-adjusted returns

Kelly Fraction

-0.0466

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.551

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-45.2%

Historical annualised return based on price data

Max Drawdown

-81.9%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

N/A

52W High

$4.00

79% below the year high

52W Low

$0.54

55% above the year low

Avg Volume

1,521,917

Average daily shares traded — higher means easier to buy and sell

Short Ratio

2.1

Days it would take all short sellers to cover — higher means more crowded

Short % Float

6.0%

Moderate short interest

Div Yield

0.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.62

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

0.00

Conservative use of debt — low financial risk

Current Ratio

0.74

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.62

Like current ratio but excludes inventory — stricter test

Gross Margin

N/A

Revenue left after cost of goods — higher means pricing power

Operating Margin

N/A

Profit from core operations before interest and tax

Free Cash Flow

$-6,583,482

Negative — the business is spending more than it generates

Revenue (TTM)

N/A

Total revenue over the last 12 months

Net Income

$-20,231,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$8.00

Target Median

$5.83

Target Low

$4.00

Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

Date	Insider	Title	Shares	Value
2026-04-16	FERRARI RICHARD M	Director	62,500	$50,000
2026-04-16	FERRARI RICHARD M	Director	57,500	$46,000
2026-04-16	ELFRINK WILLHEM P.	Director	187,500	$150,000
2026-04-16	VAJDIC BRANISLAV	Director	31,250	$25,000
2026-04-16	ORTIGAS-WEDEKIND MARGARITA	Director	25,000	$20,000
2026-04-16	STROME MARK E.	Director	750,000	$600,000
2026-04-16	ENO ROBERT PAUL	President	12,500	$10,000
2026-04-16	JAFF MICHAEL R.	Director	31,250	$25,000
2026-04-16	CRUICKSHANK TIMOTHY	Chief Financial Officer	31,250	$25,000
2026-02-09	FERRARI RICHARD M	Director	50,000	—

Source: SEC Form 4 filings via public data. View all insider activity at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15

Before you go